Document Detail

Multimodality treatment of giant intracranial arteriovenous malformations.
MedLine Citation:
PMID:  12823868     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Giant arteriovenous malformations (AVMs) (i.e., those greater than 6 cm at maximum diameter) are difficult to treat and often carry higher treatment morbidity and mortality rates than do smaller AVMs. In this study, we reviewed the treatment, angiographic results, and clinical outcomes in 53 patients with giant AVMs who were treated at Stanford between 1987 and 2001. METHODS: The patients selected included 20 males (38%) and 33 females (62%). Their presenting symptoms were hemorrhage (n = 20; 38%), seizures (n = 18; 34%), headaches (n = 8; 15%), and progressive neurological deficits (n = 7; 13%). One patient was in Spetzler-Martin Grade III, 9 were in Spetzler-Martin Grade IV, and 43 were in Spetzler-Martin Grade V. The mean AVM size was 6.8 cm (range, 6-15 cm). AVM venous drainage was superficial (n = 7), deep (n = 20), or both (n = 26). At presentation, 31 patients (58%) were graded in excellent neurological condition, 17 were graded good (32%), and 5 were graded poor (9%). RESULTS: The patients were treated with surgery (n = 27; 51%), embolization (n = 52; 98%), and/or radiosurgery (n = 47; 89%). Most patients received multimodality treatment with embolization followed by surgery (n = 5), embolization followed by radiosurgery (n = 23), or embolization, radiosurgery, and surgery (n = 23). Nineteen patients (36%) were completely cured of their giant AVMs, 90% obliteration was achieved in 4 patients (8%), less than 90% obliteration was achieved in 29 patients (55%) who had residual AVMs even after multimodality therapy, and 1 patient was lost to follow-up. Of the 33 patients who either completed treatment or were alive more than 3 years after undergoing their most recent radiosurgery, 19 patients (58%) were cured of their AVMs. The long-term treatment-related morbidity rate was 15%. The clinical results after mean follow-up of 37 months were 27 excellent (51%), 15 good (28%), 3 poor (6%), and 8 dead (15%). CONCLUSION: The results in this series of patients with giant AVMs, which represents the largest series reported to date, suggest that selected symptomatic patients with giant AVMs can be treated successfully with good outcomes and acceptable risk. Multimodality treatment is usually necessary to achieve AVM obliteration.
Steven D Chang; Mary L Marcellus; Michael P Marks; Richard P Levy; Huy M Do; Gary K Steinberg
Related Documents :
16474938 - Percutaneous ct-guided curettage of osteoid osteoma with histological confirmation: a r...
9174828 - Primary serous papillary carcinoma of the peritoneum: a report of 18 patients.
7645908 - Conservative versus operative treatment of appendicular abscess. experience of 147 cons...
19533458 - Care of children with brain and spine tumours - a review of practice.
15108488 - Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic le...
8165998 - Diagnosis of tears of the quadriceps tendon of the knee: value of sonography.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurosurgery     Volume:  53     ISSN:  0148-396X     ISO Abbreviation:  Neurosurgery     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-06-25     Completed Date:  2003-09-04     Revised Date:  2008-09-30    
Medline Journal Info:
Nlm Unique ID:  7802914     Medline TA:  Neurosurgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1-11; discussion 11-3     Citation Subset:  IM    
Department of Neurosurgery and the Stanford Stroke Center, Stanford University School of Medicine, Stanford, California 94305, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cerebral Angiography
Child, Preschool
Combined Modality Therapy
Embolization, Therapeutic / adverse effects*
Follow-Up Studies
Intracranial Arteriovenous Malformations / mortality,  radiography,  therapy*
Microsurgery / adverse effects
Middle Aged
Outcome Assessment (Health Care)*
Postoperative Complications*
Radiosurgery / adverse effects*
Retrospective Studies
Severity of Illness Index
Survival Rate
Republished in:
Neurosurgery. 2007 Jul;61(1 Suppl):432-42; discussion 442-4   [PMID:  18813147 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Statistical implications of pooling RNA samples for microarray experiments.
Next Document:  Endovascular treatment of paraclinoid aneurysms: experience with 73 patients.